The effects of homeopathic belladonna 30CH in healthy volunteers -- a randomized, double-blind experiment
- PMID: 11316508
- DOI: 10.1016/s0022-3999(00)00224-5
The effects of homeopathic belladonna 30CH in healthy volunteers -- a randomized, double-blind experiment
Abstract
Objectives: The practice of homeopathy rests on symptoms, which have been produced by medicinal substances in healthy volunteers, often applied at ultramolecular dilutions. It is unknown whether these symptom patterns are due to specific effects or chance fluctuation.
Methods: We tested the hypothesis that a homeopathic substance can bring about symptoms different from observation and placebo in a double-blind, placebo-controlled crossover design with baseline observation.
Results: 87 out of 118 healthy volunteers took both placebo and homeopathic belladonna 30CH in random sequence, after a 2-week observation period, and finished the 8-week trial. Apart from an insignificant tendency for subjects to report more symptoms with belladonna (mean number: 27.34), as compared to observation (24.26) or placebo (24.17), there was no indication that subjects reacted differently to homeopathy than to placebo or during baseline.
Conclusion: There is no indication that belladonna 30CH produces symptoms different from placebo or from no intervention. Symptoms of a homeopathic pathogenetic trial (HPT) are most likely chance fluctuations.
Similar articles
-
Ultramolecular homeopathy has no observable clinical effects. A randomized, double-blind, placebo-controlled proving trial of Belladonna 30C.Br J Clin Pharmacol. 2003 Nov;56(5):562-8. doi: 10.1046/j.1365-2125.2003.01900.x. Br J Clin Pharmacol. 2003. PMID: 14651731 Free PMC article. Clinical Trial.
-
Homeopathic pathogenetic trials produce specific symptoms different from placebo.Forsch Komplementmed. 2009 Apr;16(2):105-10. doi: 10.1159/000209386. Epub 2009 Apr 9. Forsch Komplementmed. 2009. PMID: 19420956 Clinical Trial.
-
Homeopathic proving symptoms: result of a local, non-local, or placebo process? A blinded, placebo-controlled pilot study.Homeopathy. 2004 Oct;93(4):179-85. doi: 10.1016/j.homp.2004.07.006. Homeopathy. 2004. PMID: 15532695 Clinical Trial.
-
Scientific proving of ultra high dilutions on humans.Homeopathy. 2015 Oct;104(4):322-7. doi: 10.1016/j.homp.2015.08.008. Epub 2015 Oct 12. Homeopathy. 2015. PMID: 26678737 Review.
-
A systematic review of the quality of homeopathic pathogenetic trials published from 1945 to 1995.Homeopathy. 2007 Jan;96(1):4-16. doi: 10.1016/j.homp.2006.11.005. Homeopathy. 2007. PMID: 17227742 Review.
Cited by
-
Ultramolecular homeopathy has no observable clinical effects. A randomized, double-blind, placebo-controlled proving trial of Belladonna 30C.Br J Clin Pharmacol. 2003 Nov;56(5):562-8. doi: 10.1046/j.1365-2125.2003.01900.x. Br J Clin Pharmacol. 2003. PMID: 14651731 Free PMC article. Clinical Trial.
-
Homeopathic drug proving of Okoubaka aubrevillei: a randomised placebo-controlled trial.Trials. 2013 Apr 5;14:96. doi: 10.1186/1745-6215-14-96. Trials. 2013. PMID: 23561008 Free PMC article. Clinical Trial.
-
An exploration of the relationship between placebo and homeopathy and the implications for clinical trial design.JRSM Short Rep. 2013 Jul 30;4(9):2042533313490927. doi: 10.1177/2042533313490927. JRSM Short Rep. 2013. PMID: 24040505 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
